The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CYAD-101: An innovative non-gene edited allogeneic CAR-T for solid tumor cancer therapy.
 
Hans Prenen
Honoraria - Amgen; Bayer; Lilly; Merck Serono; Novartis; Pfizer; Roche; Sanofi; TERUMO; Vifor Pharma
Consulting or Advisory Role - Amgen; Roche Molecular Diagnostics
Research Funding - Ipsen (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Ipsen; Roche
 
Jeroen Dekervel
No Relationships to Disclose
 
Sébastien Anguille
No Relationships to Disclose
 
Alain Hendlisz
No Relationships to Disclose
 
Alexandre Michaux
Employment - Celyad
 
Panagiota A Sotiropoulou
Employment - Celyad
 
David Edward Gilham
Employment - Celyad
Leadership - Celyad
Stock and Other Ownership Interests - Celyad; CTL/Immetacyte
Honoraria - Oxford Biomedica
Travel, Accommodations, Expenses - Celyad
 
Sébastien Mauen
Employment - Celyad
 
Sarah Snykers
Employment - Celyad
 
Emilie Cerf
Employment - Celyad
 
Caroline Lonez
Employment - Celyad
Stock and Other Ownership Interests - Celyad
 
Anne Flament
Employment - Celyad
 
Frederic Lehmann
Employment - Celyad
Leadership - Celyad; GlaxoSmithKline
Stock and Other Ownership Interests - Celyad; GlaxoSmithKline
Honoraria - Celyad; GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - Patent and IP at GSK
Travel, Accommodations, Expenses - Celyad; GlaxoSmithKline
 
Eric Van Cutsem
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Halozyme; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Roche; SERVIER
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst)